BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 29756635)

  • 1. Trends in the use of mammography for early breast cancer detection in Switzerland: Swiss Health Surveys 2007 and 2012.
    Fenner L; Kässner A; Berlin C; Egger M; Zwahlen M
    Swiss Med Wkly; 2018; 148():w14603. PubMed ID: 29756635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating young women's motivations to engage in early mammography screening in Switzerland: results of a cross-sectional study.
    Labrie NH; Ludolph R; Schulz PJ
    BMC Cancer; 2017 Mar; 17(1):209. PubMed ID: 28327090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of an organised screening program on socioeconomic inequalities in mammography practice, knowledge and attitudes.
    Relecom A; Arzel B; Perneger T
    Int J Equity Health; 2018 Jul; 17(1):95. PubMed ID: 29970090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of breast cancer screening mammography uptake: Results from Jordan population and family health survey.
    Obeidat RF; Lally RM
    Indian J Cancer; 2023; 60(2):266-274. PubMed ID: 37530252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-normal Screening Mammography Results, Lumpectomies, and Breast Cancer Reported by California Women, 2001-2009.
    Irvin VL; Breen N; Meissner HI; Liu B; Kaplan RM
    Womens Health Issues; 2015; 25(4):331-40. PubMed ID: 26070253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer patients enrolled in the Swiss mammography screening program "donna" demonstrate prolonged survival.
    Kuklinski D; Blum M; Subelack J; Geissler A; Eichenberger A; Morant R
    Breast Cancer Res; 2024 May; 26(1):84. PubMed ID: 38802897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early detection of breast cancer in Brazil: data from the National Health Survey, 2013.
    Silva GAE; Souza-Júnior PRB; Damacena GN; Szwarcwald CL
    Rev Saude Publica; 2017 Jun; 51(suppl 1):14s. PubMed ID: 28591356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation of colorectal, breast and prostate cancer screening activity in Switzerland: Influence of insurance, policy and guidelines.
    Ulyte A; Wei W; Dressel H; Gruebner O; von Wyl V; Bähler C; Blozik E; Brüngger B; Schwenkglenks M
    PLoS One; 2020; 15(4):e0231409. PubMed ID: 32298325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping Variation in Breast Cancer Screening: Where to Intervene?
    Padilla CM; Painblanc F; Soler-Michel P; Vieira VM
    Int J Environ Res Public Health; 2019 Jun; 16(13):. PubMed ID: 31252599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personality and breast cancer screening in women of the GAZEL cohort study.
    Lemogne C; Turinici M; Panjo H; Ngo C; Canoui-Poitrine F; Chauvet-Gelinier JC; Limosin F; Consoli SM; Goldberg M; Zins M; Ringa V
    Cancer Med; 2018 Feb; 7(2):515-524. PubMed ID: 29277970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Breast Cancer Screening Results and Influencing Factors of Breast Cancer in Guangdong Province from 2017 to 2021.
    Wu L; Chen GZ; Zeng ZR; Ji CW; Zhang AQ; Xia JH; Liu GC
    J Epidemiol Glob Health; 2024 Mar; 14(1):131-141. PubMed ID: 38224387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer screening and early diagnosis in China: a systematic review and meta-analysis on 10.72 million women.
    Li M; Wang H; Qu N; Piao H; Zhu B
    BMC Womens Health; 2024 Feb; 24(1):97. PubMed ID: 38321439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in State-Level Mammography Use, 2012 and 2020.
    Howard DH; Tangka FKL; Miller J; Sabatino SA
    Public Health Rep; 2024; 139(1):59-65. PubMed ID: 36927203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Morbidity and Disability on Attendance at Organized Breast Cancer-Screening Programs: A Systematic Review and Meta-Analysis.
    McWilliams L; Groves S; Howell SJ; French DP
    Cancer Epidemiol Biomarkers Prev; 2022 Jul; 31(7):1275-1283. PubMed ID: 35511754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer screening and its associating factors among hungarian women aged 45-65: a cross-sectional study based on the European health interview surveys from 2009 to 2019.
    Pataki J; Dombrádi V; Sárváry A; Szőllősi GJ
    BMC Public Health; 2023 Aug; 23(1):1679. PubMed ID: 37653363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast screening participation and degree of spread of invasive breast cancer at diagnosis in mental health service users: A population linkage study.
    Sara G; Lambeth C; Burgess P; Curtis J; Walton R; Currow D
    Cancer; 2024 Jan; 130(1):77-85. PubMed ID: 37632356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Still Controversial: Early Detection and Screening for Breast Cancer in Brazil, 1950-2010s.
    Teixeira LADS; Araújo Neto LA
    Med Hist; 2020 Jan; 64(1):52-70. PubMed ID: 31933502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Including the method of detection for breast cancer in the Surveillance, Epidemiology, and End Results database is long overdue.
    Kopans DB; Sharpe RE; Eby PR
    J Med Screen; 2024 Mar; 31(1):1-2. PubMed ID: 37624726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of non-compliance to recommendations on breast cancer screening among women participating in the French E3N cohort study.
    Flamant C; Gauthier E; Clavel-Chapelon F
    Eur J Cancer Prev; 2006 Feb; 15(1):27-33. PubMed ID: 16374226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. US expert panel says breast cancer screening should begin at 40.
    Tanne JH
    BMJ; 2024 May; 385():q1020. PubMed ID: 38702065
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.